Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 28801 - 28825 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Dactinomycin	Approved Investigational	AXL	558	upregulated	Dactinomycin results in increased expression of AXL mRNA	19q13.2	A21863
Dactinomycin	Approved Investigational	BAX	581	upregulated	Dactinomycin results in increased expression of BAX mRNA	19q13.33	A21863
Dactinomycin	Approved Investigational	BBC3	27113	upregulated	Dactinomycin results in increased expression of BBC3 mRNA	19q13.32	A21893
Dactinomycin	Approved Investigational	BCL2	596	downregulated	Dactinomycin results in decreased expression of BCL2 mRNA	18q21.33	A21893
Dactinomycin	Approved Investigational	BSDC1	55108	upregulated	Dactinomycin results in increased expression of BSDC1 mRNA	1p35.1	A21863
Dactinomycin	Approved Investigational	CASP3	836	downregulated	Dactinomycin results in decreased expression of CASP3 mRNA	4q35.1	A21894
Dactinomycin	Approved Investigational	CASP7	840	downregulated	Dactinomycin results in decreased expression of CASP7 mRNA	10q25.3	A21894
Dactinomycin	Approved Investigational	CASP8	841	downregulated	Dactinomycin results in decreased expression of CASP8 mRNA	2q33.1	A21894
Dactinomycin	Approved Investigational	CEBPB	1051	downregulated	Dactinomycin results in decreased expression of CEBPB mRNA	20q13.13	A21894
Dactinomycin	Approved Investigational	CEL	1056	upregulated	Dactinomycin results in increased expression of CEL mRNA	9q34.13	A21863
Dactinomycin	Approved Investigational	COL1A1	1277	downregulated	Dactinomycin results in decreased expression of COL1A1 mRNA	17q21.33	A21895
Dactinomycin	Approved Investigational	CRABP2	1382	upregulated	Dactinomycin results in increased expression of CRABP2 mRNA	1q23.1	A21863
Dactinomycin	Approved Investigational	DPYSL4	10570	upregulated	Dactinomycin results in increased expression of DPYSL4 mRNA	10q26.3	A21863
Dactinomycin	Approved Investigational	EMP1	2012	upregulated	Dactinomycin results in increased expression of EMP1 mRNA	12p13.1	A21863
Dactinomycin	Approved Investigational	EMP3	2014	upregulated	Dactinomycin results in increased expression of EMP3 mRNA	19q13.33	A21863
Dactinomycin	Approved Investigational	FADD	8772	downregulated	Dactinomycin results in decreased expression of FADD mRNA	11q13.3	A21894
Dactinomycin	Approved Investigational	FADS3	3995	upregulated	Dactinomycin results in increased expression of FADS3 mRNA	11q12.2	A21863
Dactinomycin	Approved Investigational	FGF2	2247	downregulated	Dactinomycin results in decreased expression of FGF2 mRNA	4q28.1	A21896
Dactinomycin	Approved Investigational	FLNC	2318	upregulated	Dactinomycin results in increased expression of FLNC mRNA	7q32.1	A21863
Dactinomycin	Approved Investigational	GADD45A	1647	upregulated	Dactinomycin results in increased expression of GADD45A mRNA	1p31.3	A21863
Dactinomycin	Approved Investigational	GAPDH	2597	upregulated	Dactinomycin results in increased expression of GAPDH mRNA	12p13.31	A21894
Dactinomycin	Approved Investigational	GPR137B	7107	upregulated	Dactinomycin results in increased expression of GPR137B mRNA	1q42.3	A21863
Dactinomycin	Approved Investigational	HBEGF	1839	downregulated	Dactinomycin results in decreased expression of HBEGF mRNA	5q31.3	A21896
Dactinomycin	Approved Investigational	HOMER3	9454	upregulated	Dactinomycin results in increased expression of HOMER3 mRNA	19p13.11	A21863
Dactinomycin	Approved Investigational	IER5	51278	upregulated	Dactinomycin results in increased expression of IER5 mRNA	1q25.3	A21863

Displaying entries 28801 - 28825 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability